Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medroxyprogesterone Acetate for Endometrial Pathology Prevention in Tamoxifen-Treated Breast Cancer
NCT00002920Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Mar 1997
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of medroxyprogesterone acetate in endometrial hyperplasia (EH), endometrial cancer (EC), sponsored by SWOG Cancer Research Network. Started Mar 1997; status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
endometrial hyperplasia (EH)endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00002920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002920.